HOME >> BIOLOGY >> NEWS
Rutgers-led research offers new clues in the genetic mysteries of maize

NEW BRUNSWICK/PISCATAWAY, N.J. Rutgers researchers, with the support of the National Science Foundation, have pushed back the frontiers on the genetic nature and history one of the world's most important crops corn. This crop dominates agriculture in the United States, where approximately 9 billion bushels are produced annually at a value of $30 billion. Maize (or corn) is also an important dietary staple in much of the third world.

Rutgers' Joachim Messing and his colleagues announced this month discoveries about the inner workings of corn, its origins and evolution, with implications for breeding, genetic engineering and future genomic studies.

"This latest research, conducted with worldwide collaborations, led us to a new understanding of maize that will help enable scientists and farmers to make major improvements in one of the world's most significant crops and gain new and important insights in plant genomic studies," said Messing, director of the Waksman Institute of Microbiology at Rutgers, The State University of New Jersey. The findings are presented in three papers in the journal Genome Research and one in the Proceedings of the National Academy of Sciences.

The scientists conducted the most comprehensive survey of the maize genome ever performed and established for the first time the genome's magnitude approximately 59,000 genes and the relative position of the genes. This is twice as many as the human genome and the highest number of genes of any genome sequenced to date. Messing emphasized that this survey is only a first step and conducting a whole genome sequence is a priority dictated by nutritional, economic and societal needs.

The research further established that in addition to its immense size, the corn genome is extremely complex due, in part, to positional instability as well as its genetic history. Messing and his colleagues concluded that maize genes are scrambled, having moved around to different locat
'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
12-Oct-2004


Page: 1 2

Related biology news :

1. Rutgers-led group lands $2.55 million to advance high school biology and math
2. National Science Foundation awards $15 million grant to Rutgers-led engineering research consortium
3. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
4. Saudi Arabias KAUST names WHOI first research partner
5. Multinational research: protecting ecology means understanding people, too
6. Newly created cancer stem cells could aid breast cancer research
7. Carnegie Mellons Peter Adams receives EPA research grant
8. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
9. Innovative tagging technique may help researchers better protect fish stocks
10. Penn researchers discover how key protein stops inflammation
11. UCF research links proteins, stem cells and potential Alzheimers treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rutgers led research offers new clues the genetic mysteries maize

(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... and POINT ROBERTS, Washington , January 20, ... leading sectors including technology and tech stocks, releases video from ... master pickpocket and security consultant Apollo Robbins . ... talks about the Wocket™ biometric smart wallet, a product of ...
(Date:1/22/2015)... , January 22, 2015 , ... year  The European Patent Office to present a video ... British nominations to be featured: Christofer Toumazou and ... former finalists and winners of the Award   Starting ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently ... Supplements Pre-Conference seminar on probiotics in San Diego, CA. ... education conference for health care professionals. This year’s pre-conference seminar ... probiotics in health. Dr. Leyer spoke about the emerging topics ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
(Date:12/24/2014)... Missouri (PRWEB) December 23, 2014 GMO corn ... company, Syngenta, are in the process of being consolidated in ... is In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... of Kansas. , Management of the Syngenta GMO corn multidistrict ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
Cached News: